Ultromics announced that the American Medical Association (AMA) has issued a Category III Current Procedural Terminology (CPT) code for EchoGo® Heart Failure, a crucial advancement in enhancing the accessibility of Ultromics' ground-breaking technology in hospital outpatient settings.
EchoGo® Heart Failure uses AI to detect heart failure with preserved ejection fraction (HFpEF)...
Collaboration brings together Rad AI’s generative AI radiology reporting solutions and patient follow-up management solution with Bayer’s Calantic™ Digital Solution Platform
As experts from around the globe gather at the annual Society for Informatics in Medicine (SIIM) conference, Bayer and Rad AI are announcing a collaboration to bring Rad AI’s...
RamSoft®, a global leader in cloud-based RIS/PACS radiology solutions, and RADPAIR, a trailblazer in healthcare technology, proudly announce the integration of AI-driven radiology report generation into the OmegaAI® platform. This collaboration marks a pivotal advancement in AI-driven enterprise imaging by combining RamSoft's OmegaAI, a PACS/RIS/VMA platform with RADPAIR's cutting-edge Gen AI platform...
Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming Mass General Cancer Center
Caris Life Sciences, the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and...
EvolutionaryScale, a frontier AI research lab for biology, launched with ESM3, a milestone AI model capable of generating novel proteins. ESM3 generated a new Green Fluorescent Protein (GFP), a process that would take 500 million years of evolution to occur naturally. This milestone generative AI model allows interactive prompting...
Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of Series D financing. The financing was led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced a new collaboration with United Therapeutics (UT), a leading biotechnology company focused on providing a brighter future for patients through the development of novel pharmaceuticals and technologies. As part of this collaboration, Tempus will develop and investigate...
BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, announced a strategic collaboration with Genomic Testing Cooperative (GTC), a leading provider of molecular diagnostics for solid tumors and hematologic malignancies. This collaboration leverages the AI capabilities of both companies to deliver...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus (SLE) to its discovery portfolio through its collaboration with BenevolentAI.
Second target to be selected this year from the extended collaboration with AstraZeneca, highlighting continued...
Life Sciences BC (LSBC) is pleased to announce the recipients of the 26th Annual Life Sciences BC Awards presented by Farris. These awards recognize the exceptional achievements of individuals, companies, and organizations across British Columbia’s life sciences sector that have successfully advanced health innovations and significantly enriched our dynamic...
